-
Pfizer cuts Norway's COVID-19 vaccine deliveries, rollout delayed
firstwordpharma
June 11, 2021
July deliveries of Pfizer’s COVID-19 vaccine to Norway have been cut by 400,000 doses, delaying the country’s vaccine rollout, the company and the Norwegian Institute of Public Health (FHI) said on Thursday, as reported by This is Money.
-
U.S. to Send 500 Million COVID-19 Vaccine Doses to Countries Desperate for Shots
drugs
June 11, 2021
The United States plans to purchase 500 million doses of Pfizer's coronavirus vaccine that it will then donate to countries in need around the world.
-
FDA okays Pfizer's Prevnar 20 pneumococcal conjugate vaccine
firstwordpharma
June 09, 2021
Pfizer announced Tuesday that the FDA approved Prevnar 20 to prevent invasive disease and pneumonia caused by 20 Streptococcus pneumoniae serotypes in adults.
-
MHRA authorises Pfizer/BioNTech’s COVID-19 vaccine for 12- to 15-year-olds
pharmatimes
June 08, 2021
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has extended the authorisation of Pfizer/BioNTech’s COVID-19 vaccine for use in children aged 12 to 15 years old.
-
Covid-19 vaccines show efficacy in adolescents, paving path towards herd immunity
pharmaceutical-technology
June 08, 2021
There are globally now more people vaccinated for COVID-19 than confirmed cases of COVID-19. With globally over 400 million people fully vaccinated and over 1.7 billion vaccine doses administered, herd immunity seems achievable.
-
Exelead Helps Manufacture Pfizer-BioNTech COVID-19 Vaccine
contractpharma
June 08, 2021
Pharmaceutical development and manufacturing company delivers first vaccine batch to Pfizer.
-
Pfizer/BioNTech COVID-19 vaccine approved for young people in Switzerland
firstwordpharma
June 07, 2021
Swissmedic approves indication extension for Comirnaty® for 12 to 15-year-olds
-
Pfizer Covid-19 vaccine approved for adolescents in the UK
pharmaceutical-technology
June 07, 2021
The approval of Pfizer and BioNTech’s Covid-19 vaccine COMIRNATY in the UK has been expanded to include individuals between 12 and 15 years of age.
-
Vaccine Protection May Diminish Need for Yearly Boosters
firstwordpharma
June 03, 2021
Scientists have found clues that the world's leading COVID-19 vaccines offer lasting protection that could reduce the need for frequent booster shots, as reported in U.S. News & World Report.
-
Long-Haul COVID Symptoms? Getting Vaccine Won't Make You Feel Worse, Study Finds
drugs
June 02, 2021
COVID survivors can relax when it comes to vaccination: A new study shows that getting immunized will not worsen any symptoms that linger long after infection, such as breathing difficulties, fatigue and insomnia.